Comprehensive MYTESI Market Analysis for Chemotherapy-Induced Diarrhea Revealed in New 2032 Forecast Report [Yahoo! Finance]
Jaguar Health, Inc. (JAGX)
US:NASDAQ Investor Relations:
jaguarhealth.gcs-web.com/investor-overview
Company Research
Source: Yahoo! Finance
A new report unveils a thorough market evaluation of MYTESI, an investigational drug for the treatment of Chemotherapy-induced Diarrhea (CID). This evaluative study provides insights into the current state and future prospects of MYTESI in the treatment landscape of CID across major global markets, including the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan. Drug Summary and Clinical Impact MYTESI, developed by Napo Pharmaceuticals, represents a novel approach in managing CID with its distinct mechanism of action as an antisecretory agent. It showcases potential for significant benefits in patients experiencing gastrointestinal distress caused by various underlying conditions. The drug specifically targets chloride and fluid secretion in the GI tract to alleviate symptoms of secretory diarrhea. Scope and Depth of the Report The report encompasses crucial developmental milestones and regulatory achievements for MYTESI, alongside an analysis
Show less
Read more
Impact Snapshot
Event Time:
JAGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAGX alerts
High impacting Jaguar Health, Inc. news events
Weekly update
A roundup of the hottest topics
JAGX
News
- Jaguar Health, Inc. Announces Reverse Stock Split [Yahoo! Finance]Yahoo! Finance
- Jaguar Health, Inc. Announces Reverse Stock SplitAccesswire
- Jaguar Health, Inc. (NASDAQ: JAGX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Jaguar Health Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Jaguar Health Reports First Quarter 2024 Financial ResultsAccesswire
JAGX
Sec Filings
- 5/14/24 - Form 10-Q
- 5/10/24 - Form PRE
- 5/2/24 - Form EFFECT
- JAGX's page on the SEC website